Unmet Medical Need Forum 2012

Preparing for the drug therapies required to combat tomorrow’s illnesses of high socioeconomic impact

It is now widely known that healthcare systems around the world are already under significant budgetary pressure, with the prognosis for the future looking far from positive. Ageing populations, growing incidents of chronic disease that effect large patient populations, costly acute specialty conditions, expensive treatments for rare-diseases and the widespread use of more effective, yet expensive drugs and technologies are some of the main drivers. Governments are well aware that investing in a healthier population results in a richer and happier population. Medicines that can dramatically improve quality of life can help to keep patients out of expensive hospital care and often back into the
workforce as productive members of society.

Why this event?

• Discuss payers and policy makers views regarding their disease indications and public health investment
  priorities today and in the future.
• Understand what are the payer's priorities to make long-term R&D investment decisions.
• Learn what are products that payers want to pay for and will generate return on investment.
• Foster closer co-operation between both groups of key stakeholders.
• Help encourage medical “innovation” and to improve patient access to high-value medications and
  devices.

Who will benefit?

PAYERS & POLICY MAKERS: Senior representatives from Payers, health plans & insurers, Public health experts, health technology assessors, hospital financial management, government & health ministry officials, health management and managed care organizations, epidemiology, horizon scanning, scientific advice, pharmacy strategy & budget management.

INDUSTRY: Corporate senior management, strategic marketing, business analysis, portfolio strategy & management, corporate & business development health economics, outcomes and market access, epidemiology, health policy, government and stakeholder relations, chief medical officers, R&D strategy, financial strategy.

OTHER STAKEHOLDERS: Regulatory agencies, key-opinion-leaders, independent health economists, health researchers and academics, physicians, patient groups.

Agenda request

To request the full agenda please follow the link:

https://www.nextlevelpharma.com/events/request_agenda/unmet_medical_need_forum

For Booking Information contact:

Erika Vavrovicova

Tel: +421 232 660 382
Email: erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com

Visit website from Unmet Medical Need Forum 2012 »